# Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder

> **NCT02812368** · PHASE2 · WITHDRAWN · sponsor: **Ohio State University**

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Clonidine
- **DRUG:** Placebo (for clonidine)

## Key facts

- **NCT ID:** NCT02812368
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Failure to recruit
- **Last updated:** 2017-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02812368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02812368, "Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02812368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*